Clinical Trials Browser

Phase 2 × pixantrone × Lymphoid × Clear all

NCT03458260 2026-03-10

Study of Pixantrone in CD20+ Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma

Phase 2 Completed

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT02499003 2022-03-31

GOAL: GA101 Plus Pixantrone for Relapsed Aggressive Lymphoma

Phase 2 Completed

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse